C12Y 111/01015
Peroxiredoxin
Official title: Peroxiredoxin (1.11.1.15)
C12Y111/01015 (Peroxiredoxin) appears on 10 US grants and 26 published applications in this corpus.
Search patents in C12Y- Granted patents
- 10
- Published applications
- 26
- Assignees
- 21
- Inventors
- 53
- Latest grant
- 10 Jun 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 2 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 1 | 1 |
| 2011 | 1 | 3 |
| 2012 | 0 | 1 |
| 2013 | 0 | 1 |
| 2014 | 0 | 2 |
| 2015 | 2 | 0 |
| 2016 | 1 | 2 |
| 2017 | 1 | 2 |
| 2018 | 1 | 2 |
| 2019 | 0 | 1 |
| 2020 | 2 | 0 |
| 2021 | 0 | 2 |
| 2022 | 0 | 2 |
| 2023 | 0 | 1 |
| 2024 | 0 | 1 |
| 2025 | 1 | 0 |
By publication year.
Recent patents
- Metabolic enzyme activity and disulfide bond reduction during protein production10 Jun 2025US 12,325,875 B2Bristol-Myers Squibb Company
- Causative genes conferring acetic acid tolerance in yeast7 Apr 2020US 10,612,049 B2Katholieke Universiteit Leuven, KU LEUVEN R&D
- Reduction of lipase activity in product formulations25 Feb 2020US 10,570,397 B2University of Deleware
- Reduction of lipase activity in product formulations3 Apr 2018US 9,932,591 B2University of Delaware
- Application of PRDX2 and/or PRDX6 in improving sperm quality or treating male infertility7 Mar 2017US 9,585,944 B2Yantai Ju Jie Bioengineering Limited Company
- Multimeric proteins of the peroxiredoxin family as scaffold proteins8 Feb 2024US 2024/0043824 A1Centra National De La Recherche Scientifique - Cnrs -
- Peroxiredoxin 6 or a synthetic analogue thereof for use as a hypoglycaemic agent11 May 2023US 2023/0141985 A1Universita' Degli Studi Di Roma "Tor Vergata"
- Vaccine formulations22 Sep 2022US 2022/0296704 A1Equaly S.A.
- Biomarker for predicting ability of mesenchymal stem cells to proliferate and migrate17 Feb 2022US 2022/0049223 A1Corestem Co., Ltd.
- Synthetic genes15 Jul 2021US 2021/0214745 A1Corteva Agriscience LLC
Most cited
By later US patents
- Synthetic genes2US 9,427,003 B2Dow AgroSciences LLC · 2016
- Reduction of lipase activity in product formulations2US 9,932,591 B2University of Delaware · 2018
- Antioxidant pharmaceutical compound, method for producing polypeptide and method of cure1US 8,003,345 B2Institute of Cell Biophysics Russian Academy of Sciences · 2011